Aster DM Quality Care Limited – Q2 FY27 Financial and Operational Highlights
Aster DM Quality Care Limited, the integrated healthcare platform formed by the merger of Aster DM Healthcare Limited and Quality Care India Limited, released its financial results for the quarter ended 30 September 2026, its first full quarter as a combined entity. The company recorded revenue of INR 2,829 crore, representing a 19% year‑on‑year increase. Normalised profit after tax (PAT) reached INR 281 crore, up 34% YoY, delivering a PAT margin of 10%. Return on capital employed (ROCE) improved to 23%, a rise of 152 basis points from the prior year.
Operationally, the network served 2.2 million patients, a 12% YoY growth, and occupancy rose 335 basis points to 68% (from 65%). Medical Value Travel (MVT) revenue grew 36% YoY, driven primarily by demand from the Maldives, GCC, and expanding contributions from West Africa and other MENA markets.
The emerging hospital portfolio, which includes the Kasargod and Nagarcoil facilities, posted a 61% YoY increase in revenue, underscoring the growing contribution of newer sites. Mature hospitals contributed roughly 73% of total hospital revenue in H1 FY27 and posted an 18% YoY revenue growth supported by higher patient volumes and a larger share of complex clinical cases.
Clinical activity saw robust expansion: robotic surgeries rose approximately 39%, kidney transplants 31%, and joint replacements 29% YoY. The network performed its first adaptive Deep Brain Stimulation procedure for Parkinson’s disease at CARE Banjara, Hyderabad, and Aster Medcity, Kochi, delivered Kerala’s inaugural liquid‑nitrogen cryoablation for breast fibroadenomas. Three new Centres of Excellence were launched – the ARISE Robotic Spine Institute at Aster CMI, Bengaluru; the CARE Cancer Institute at Ramkrishna CARE, Raipur; and the Fetal Medicine Centre of Excellence at Aster Medcity, Kochi.
Quality recognitions included JCI accreditation for CARE Hospitals, HITEC City, Hyderabad, and NABH accreditation for MIMS Kasargod within a year of operation. The company also received multiple awards at the Global ESG Awards 2026 for initiatives supporting economically weaker sections, renewable energy integration, and CSR excellence.
Looking ahead, Aster DM Quality Care highlighted its focus on expanding the Aster Trivandrum project toward commissioning, augmenting capacity across geographies, strengthening clinical talent, and advancing high‑end specialties such as CONGO. The leadership reaffirmed its commitment to delivering better patient outcomes, operational excellence, and sustainable long‑term value for stakeholders.